Discrimination in the discretionary points award scheme: comparison of white with non-white consultants and men with women.

studying medication administration errors. Am J Health Syst Pharm 2001;58:54-9. 12 Dean BS, Barber ND. A validated, reliable method of scoring the severity of medication errors. Am J Health Syst Pharm 1999;56:57-62. 13 Department of Health and Social Security. Report of the working party on the addition of drugs to intravenous infusion fluids (Breckenridge report). London: DHSS, 1976. 14 Brzozowski DF, Hale KM, Segal R, Mirtallo JM. Pharmacists’ opinion about and compliance with recommendations for intravenous admixture practices. Am J Health Syst Pharm 1987;44:2077-84. 15 Delaney T. EAHP survey of hospital-based pharmaceutical services in Europe, 1995. Eur Hosp Pharm 1996;2:92-105. 16 Armour DJ, Cairns CJ, Costello I, Riley SJ, Davies EG. The economics of a pharmacy-based central intravenous additive service for pediatric patients. PharmacoEconomics 1997;10:386-94. 17 Chan R, Ryan M,Moriarty S, Feely J, Sabra K. The impact of a centralized reconstitution of intravenous additives service on administration times of intravenous antibiotics. Eur J Hosp Pharm 1993;3:93-5. 18 Cousins DH, Lee M, Stanaway M, Neary C. Implementation and evaluation of a centralised IV additive service for antibiotic injections. Pharm J 1989;242:HS14-6. 19 Wilson M. An evaluation of the cost effectiveness of a centralised intravenous admixture service. Proc Guild 1990;27:3-11. 20 Allan Flynn E, Pearson RE, Barker KN. Observational study of accuracy in compounding iv admixtures at five hospitals. Am J Health Syst Pharm 1997;54:904-12. 21 Mays N, Pope C. Observational methods in health care settings. BMJ 1995;311:182-4.